GCC Medical Tourism Market Size, Share, and Report 2026-2034

IMARC Group, a leading global market research and management consulting firm, has published its latest market intelligence report on the GCC Medical Tourism Market. The GCC medical tourism market size increased from USD 9.6 Billion in 2025 to USD 10.5 Billion in 2026 and is projected to reach USD 22.5 Billion by 2034, exhibiting a CAGR of 9.94% during 2026-2034. Growth is being driven by advanced healthcare infrastructure, the quality of services, and government initiatives and support, while the integration of digital health technologies, the rise of wellness tourism and a growing focus on specialized treatments add to market expansion.

The Gulf has built hospitals, specialist centers and patient journeys that now draw international patients from Asia, Africa, Europe and neighboring Arab countries for cosmetic surgery, dentistry, cardiac care, orthopedics, fertility treatment and diagnostics. Globally accredited facilities, specialists trained or certified in Western countries, shorter waiting times than in many home markets and a luxury hospitality sector that wraps care in comfort are the region’s main selling points. Governments are backing the sector with health tourism portals, visa reforms, insurance incentives and national health strategies, and providers are adding telemedicine, electronic health records and AI to manage the journey before, during and after treatment. At the same time, the 2026 regional conflict has disrupted travel and sentiment, and Dubai positions itself on quality and orchestration rather than price against Turkey and India. Combined with strong demand in the UAE and Saudi Arabia and growing offerings in Qatar, Bahrain, Kuwait, and Oman, these forces are shaping a high-growth, long-term path for the market, supporting the GCC medical tourism market growth outlook.

GCC Medical Tourism Market at a Glance:

  • Market Size (2025): USD 9.6 Billion
  • Market Size (2026): USD 10.5 Billion
  • Market Forecast (2034): USD 22.5 Billion
  • Growth Rate (2026-2034): CAGR of 9.94%
  • Base Year: 2025 | Historical Period: 2020-2025 | Forecast Period: 2026-2034

How AI is Reshaping the Future of the GCC Medical Tourism Market

  • Digital Integration of Health and Immigration Systems: In June 2026, the Dubai Health Authority and Dubai’s General Directorate of Identity and Foreigners Affairs signed an agreement to link their digital systems, so providers on the Dubai Health Experience portal can apply for medical visas on patients’ behalf and handle companion visas and extensions. Analysts said the planned smart medical visa shifts the experience from planning a complex trip to a coordinated care journey.
  • AI-Based Diagnostics, Telemedicine and Digital Records: The report highlights telemedicine, electronic health records and AI-based diagnostics as technologies that let international patients consult specialists before they travel, improve diagnostic accuracy and streamline communication among providers. It cites Dubai Health’s AI-based innovations, including a VR experience at its Thalassemia Center, and Dubai’s providers are strengthening pre-arrival engagement through virtual consultations and case reviews.
  • Abu Dhabi’s AI and Wearable-Led Preventive Care: The Department of Health – Abu Dhabi announced a research programme with ŌURA in May 2026 and a strategic collaboration with WHOOP in October 2026 on continuous health insights, while M42 began a wearable health pilot in October 2026 for patients with kidney disease and diabetes. These programs support Abu Dhabi’s positioning as a hub for advanced, data-driven care.

Grab a sample PDF of this report: https://www.imarcgroup.com/gcc-medical-tourism-market/requestsample

GCC Medical Tourism Market Trends and Drivers:

Demand for medical tourism in the GCC is being underpinned by quality, speed and accessibility. Dubai alone welcomed 691,478 international medical tourists in 2023, more than twice the number seven years earlier, who spent a reported AED 1.03 billion directly on health care and a further AED 2.3 billion on other services. A large population can reach the UAE in five to six hours, and Dubai focuses on high-value planned care such as orthopedics, aesthetics, diagnostics and dentistry, with growth potential in oncology, cardiology and reproductive medicine, according to analysts quoted by The National.

The market’s structural differentiator is the merging of health care with hospitality and digital convenience. The report highlights the rise of wellness tourism, as visitors combine medical procedures with detox, physiotherapy and spa programs, and a shift toward specialized treatments such as cosmetic surgery, fertility and orthopedics, with Al Zahra Hospital Dubai reporting more than 400 robotic surgeries by 2024. The UAE healthcare market is estimated at USD 30-33 billion in 2026 and projected to reach USD 60 billion by 2030, according to bioNixus, with 13,772 healthcare facilities nationwide in the second quarter of 2026, based on Zavis data.

A third driver, and a test, is how quickly demand recovers from the 2026 regional conflict. An analyst at Arthur D Little Middle East said in June 2026 that the conflict between the US and Iran, during which Tehran launched missile and drone attacks on the UAE, had definitely affected the market, but that given Dubai’s past resilience, the sector could recover by the end of the year or early 2027. Governments are responding with visa simplification, insurance incentives and digital portals, a dynamic that is set to intensify over the coming decade.

Government Schemes and National Initiatives Shaping Demand:

  • Dubai Smart Medical Visa (DHA and GDRFA Agreement): Signed in June 2026, the agreement links the health and immigration systems covering everything from applying for a medical visa to completing treatment, lets hospitals initiate and digitize applications, and supports companion visas and extensions, with the smart medical visa and further patient-experience services planned as follow-ups.
  • Dubai Health Experience Portal and Dubai Economic Agenda D33: Dubai has launched specialized medical tourism portals that offer treatment, travel and accommodation packages, and the report notes that the Dubai Health Authority and the Dubai Department of Economy and Tourism signed an MoU in 2024 to strengthen medical tourism and attract healthcare investment under the Dubai Economic Agenda, D33.
  • Abu Dhabi Complimentary Medical Travel Insurance: From July to December 2026, Etihad Airways and the Department of Culture and Tourism – Abu Dhabi provide complimentary medical travel insurance, underwritten by Daman, to eligible international visitors arriving in Abu Dhabi on Etihad flights, for up to 15 days. Pre-existing conditions are not covered, and the program aims to boost visitor confidence.
  • Saudi Vision 2030 and the Health Sector Transformation Program: Saudi Arabia’s Health Sector Transformation Program places healthcare capacity and private-sector participation within the broader Vision 2030 agenda, and the report notes that Vision 2030 promotes medical tourism by improving service quality and attracting global patients, particularly in oncology, cardiovascular and orthopedic care.
  • UAE National Strategy for Wellbeing 2031 and Health Innovation Strategies: The UAE has launched initiatives including the Emirates Health Services Innovation Strategy 2023-2026 and the National Strategy for Wellbeing 2031, and Abu Dhabi’s medical tourism e-portal, launched in 2018, lists dozens of facilities and almost 300 treatment packages, supporting the country’s position as a health tourism destination.

GCC Medical Tourism Market Industry Segmentation:

The report has segmented the market into the following categories:

Breakup By Treatment Type:

  • Cosmetic Treatment
  • Dental Treatment
  • Cardiovascular Treatment
  • Orthopaedic Treatment
  • Others

The report provides a detailed breakup and analysis of cosmetic, dental, cardiovascular, orthopaedic and other treatments, with cosmetic procedures such as rhinoplasty, liposuction, Botox and laser treatments drawing patients to advanced facilities and expert doctors, dental care offering cutting-edge technology and competitive pricing, and orthopaedics benefiting from advanced surgical techniques and rehabilitation, while analysts note Dubai’s particular strength in orthopedics, aesthetics, diagnostics and dentistry.

Breakup By Gender:

  • Male
  • Female

The report provides a detailed breakup and analysis of male and female patients, with male patients opting for specialized treatments such as urology, orthopedic care, cardiovascular procedures and wellness programs, and female patients driven by gynecology, fertility treatments, cosmetic procedures and wellness therapies, supported by personalized care and the reputation of specialists.

Breakup By Service Provider:

  • Private
  • Public

The report provides a detailed breakup and analysis of private and public service providers, with private hospitals, clinics and specialized centers attracting global patients through shorter waiting times, international accreditations and first-class service, as seen in Aster’s plan to reach more than 100 UAE clinics by 2030, while public providers support the sector through quality care at affordable rates and government-run initiatives such as Dubai Health’s Dubai Health Experience portal.

Breakup By Country:

  • Saudi Arabia
  • UAE
  • Qatar
  • Bahrain
  • Kuwait
  • Oman

The report provides a comprehensive analysis of all the major regional markets, including Saudi Arabia, the UAE, Qatar, Bahrain, Kuwait and Oman, with Saudi Arabia building oncology, cardiovascular and orthopedic capacity under Vision 2030, the UAE the leading hub with Dubai the largest destination and Abu Dhabi adding insurance incentives, Qatar focused on orthopedics, cardiology and oncology, Bahrain on fertility, dermatology and wellness, Kuwait on oncology, cardiology and dentistry, and Oman on orthopedics, cardiology and wellness therapies.

Competitive Landscape:

The GCC medical tourism market features intense competition driven by advancements in healthcare infrastructure, government initiatives and the integration of digital technologies. The report provides a comprehensive analysis of the competitive landscape in the GCC medical tourism market with detailed profiles of all major companies. Key players include internationally accredited hospitals and specialized clinics in the UAE, Saudi Arabia and Qatar, such as American Hospital Dubai, Al Zahra Hospital Dubai, Zulekha Hospital, Aster DM Healthcare, Thumbay Medical Tourism, Saudi German Hospital, Cleveland Clinic Abu Dhabi and M42, competing through high-quality care, cutting-edge treatments and tailored medical tourism packages, with collaboration among global healthcare providers, facilitators and the luxury hospitality sector enhancing competitiveness.

What Does The Full Report Cover?

  • Historical, current, and forecast market size for the GCC medical tourism market from 2020 to 2034
  • Market breakup by treatment type, gender, service provider, and country
  • Country analysis covering Saudi Arabia, the UAE, Qatar, Bahrain, Kuwait, and Oman
  • Key growth drivers, challenges, and opportunities shaping the market
  • Porter’s Five Forces analysis of new entrants, competitive rivalry, supplier power, buyer power, and threat of substitution
  • Competitive landscape, market structure, and player positioning
  • Detailed profiles of major medical tourism companies in the GCC

Recent News and Developments in the GCC Medical Tourism Market

  • October 2026: UK-based The Medical Travel Company and Dubai-headquartered Nuqaim Holdings announced a partnership to attract international patients to the UAE for treatment, as the UAE has 13,772 healthcare facilities and Dubai welcomed more than 690,000 international medical tourists in 2023.
  • July 2026: Aster set out an expansion plan targeting more than 100 clinics in the UAE by 2030, as private providers scale up capacity that serves both residents and inbound medical tourists.
  • June 2026: Etihad Airways and the Department of Culture and Tourism – Abu Dhabi announced on 12 June complimentary medical travel insurance with Daman for eligible international visitors flying to or through Abu Dhabi from July to December 2026.
  • June 2026: The Dubai Health Authority and Dubai’s General Directorate of Identity and Foreigners Affairs agreed on 3 June to link their digital systems and develop a smart medical visa to streamline patient journeys.
  • October 2025: M42 announced partnerships with the Medical Tourism Association and Mastercard to boost the UAE’s global patient reach, as Abu Dhabi positioned itself as a hub for advanced medical care.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

Key Questions This Report Answers

  • How big is the medical tourism market in the GCC and what is its growth outlook through 2034?
  • What are the key factors driving the GCC medical tourism market?
  • How is the market split by treatment type, gender, service provider, and country?
  • How are visa reforms, insurance incentives, and health tourism portals supporting growth?
  • How are telemedicine, AI diagnostics, and wellness tourism reshaping the patient journey?
  • Who are the leading companies in the GCC medical tourism market, and how is the competitive landscape evolving?
  • How are regional conflict and travel disruptions affecting medical tourism demand?

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Media and Sales Contact

IMARC Group

Email: sales@imarcgroup.com

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104

Leave a Reply

Your email address will not be published. Required fields are marked *